{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T07:04:01Z","timestamp":1768979041860,"version":"3.49.0"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,9,10]],"date-time":"2024-09-10T00:00:00Z","timestamp":1725926400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,9,10]],"date-time":"2024-09-10T00:00:00Z","timestamp":1725926400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Commun Biol"],"DOI":"10.1038\/s42003-024-06822-1","type":"journal-article","created":{"date-parts":[[2024,9,10]],"date-time":"2024-09-10T18:02:32Z","timestamp":1725991352000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["A serum B-lymphocyte activation signature is a key distinguishing feature of the immune response in sarcoidosis compared to tuberculosis"],"prefix":"10.1038","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9350-5133","authenticated-orcid":false,"given":"Ikhwanuliman","family":"Putera","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin","family":"Schrijver","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P. Martijn","family":"Kolijn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0698-4672","authenticated-orcid":false,"given":"Astrid C.","family":"van Stigt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Josianne C. E. M.","family":"ten Berge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanna","family":"IJspeert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicole M. A.","family":"Nagtzaam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4339-8189","authenticated-orcid":false,"given":"Sigrid M. A.","family":"Swagemakers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan A. M.","family":"van Laar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rupesh","family":"Agrawal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saskia M.","family":"Rombach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P. Martin","family":"van Hagen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rina","family":"La Distia Nora","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5235-3156","authenticated-orcid":false,"given":"Willem A.","family":"Dik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,9,10]]},"reference":[{"key":"6822_CR1","doi-asserted-by":"publisher","first-page":"S240","DOI":"10.1016\/j.ijmyco.2016.09.031","volume":"5","author":"E Mortaz","year":"2016","unstructured":"Mortaz, E. et al. Common features of tuberculosis and sarcoidosis. Int. J. Mycobacteriol. 5, S240\u2013S241 (2016).","journal-title":"Int. J. Mycobacteriol."},{"key":"6822_CR2","doi-asserted-by":"crossref","unstructured":"Giorgiutti, S. et al. Sarcoidosis-related uveitis: a review. J. Clin. Med. 12 (2023).","DOI":"10.3390\/jcm12093194"},{"key":"6822_CR3","first-page":"e11662","volume":"12","author":"A Pedroso","year":"2020","unstructured":"Pedroso, A., Ferreira, I. & Chikura, T. Tuberculosis and sarcoidosis overlap: a clinical challenge from diagnosis to treatment. Cureus 12, e11662 (2020).","journal-title":"Cureus"},{"key":"6822_CR4","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/s41572-019-0096-x","volume":"5","author":"J Grunewald","year":"2019","unstructured":"Grunewald, J. et al. Sarcoidosis. Nat. Rev. Dis. Prim. 5, 45 (2019).","journal-title":"Nat. Rev. Dis. Prim."},{"key":"6822_CR5","doi-asserted-by":"publisher","first-page":"2153","DOI":"10.1056\/NEJMra071714","volume":"357","author":"MC Iannuzzi","year":"2007","unstructured":"Iannuzzi, M. C., Rybicki, B. A. & Teirstein, A. S. Sarcoidosis. N. Engl. J. Med 357, 2153\u20132165 (2007).","journal-title":"N. Engl. J. Med"},{"key":"6822_CR6","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1007\/s12016-015-8481-z","volume":"49","author":"ES Chen","year":"2015","unstructured":"Chen, E. S. & Moller, D. R. Etiologies of sarcoidosis. Clin. Rev. Allergy Immunol. 49, 6\u201318 (2015).","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"6822_CR7","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.tube.2016.01.003","volume":"98","author":"R Agrawal","year":"2016","unstructured":"Agrawal, R. et al. Tuberculosis or sarcoidosis: opposite ends of the same disease spectrum? Tuberculosis (Edinb.) 98, 21\u201326 (2016).","journal-title":"Tuberculosis (Edinb.)"},{"key":"6822_CR8","doi-asserted-by":"publisher","first-page":"369","DOI":"10.4103\/ijri.IJRI_200_17","volume":"27","author":"AS Bhalla","year":"2017","unstructured":"Bhalla, A. S. et al. Dilemma of diagnosing thoracic sarcoidosis in tuberculosis endemic regions: an imaging-based approach. Part 1. Indian J. Radiol. Imaging 27, 369\u2013379 (2017).","journal-title":"Indian J. Radiol. Imaging"},{"key":"6822_CR9","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.4103\/ijo.IJO_2830_21","volume":"70","author":"GAD O\u2019Keefe","year":"2022","unstructured":"O\u2019Keefe, G. A. D. & Rao, N. A. Progress in the diagnosis of ocular sarcoidosis. Indian J. Ophthalmol. 70, 1121\u20131129 (2022).","journal-title":"Indian J. Ophthalmol."},{"key":"6822_CR10","doi-asserted-by":"publisher","first-page":"e297","DOI":"10.1371\/journal.pmed.0030297","volume":"3","author":"D McGonagle","year":"2006","unstructured":"McGonagle, D. & McDermott, M. F. A proposed classification of the immunological diseases. PLoS Med. 3, e297 (2006).","journal-title":"PLoS Med."},{"key":"6822_CR11","doi-asserted-by":"publisher","first-page":"991394","DOI":"10.3389\/fmed.2022.991394","volume":"9","author":"L Rizzi","year":"2022","unstructured":"Rizzi, L., Sabb\u00e0, C. & Suppressa, P. Sarcoidosis and autoimmunity: In the depth of a complex relationship. Front. Med. (Lausanne) 9, 991394 (2022).","journal-title":"Front. Med. (Lausanne)"},{"key":"6822_CR12","doi-asserted-by":"publisher","first-page":"2088","DOI":"10.7150\/thno.81488","volume":"13","author":"Z Ludi","year":"2023","unstructured":"Ludi, Z. et al. Diagnosis and biomarkers for ocular tuberculosis: from the present into the future. Theranostics 13, 2088\u20132113 (2023).","journal-title":"Theranostics"},{"key":"6822_CR13","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1128\/IAI.00732-06","volume":"75","author":"WP Drake","year":"2007","unstructured":"Drake, W. P. et al. Cellular recognition of Mycobacterium tuberculosis ESAT-6 and KatG peptides in systemic sarcoidosis. Infect. Immun. 75, 527\u2013530 (2007).","journal-title":"Infect. Immun."},{"key":"6822_CR14","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2020.527433","volume":"7","author":"YB Zhao","year":"2020","unstructured":"Zhao, Y. B. et al. Distinct miRNA gene expression profiles among the nodule tissues of lung sarcoidosis, tuberculous lymphadenitis and normal healthy control individuals. Front. Med. (Lausanne) 7, 527433 (2020).","journal-title":"Front. Med. (Lausanne)"},{"key":"6822_CR15","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1164\/rccm.201106-1143OC","volume":"184","author":"LL Koth","year":"2011","unstructured":"Koth, L. L. et al. Sarcoidosis blood transcriptome reflects lung inflammation and overlaps with tuberculosis. Am. J. Respir. Crit. Care Med. 184, 1153\u20131163 (2011).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"6822_CR16","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1038\/s42003-020-01318-0","volume":"3","author":"Q Chai","year":"2020","unstructured":"Chai, Q. et al. Lung gene expression signatures suggest pathogenic links and molecular markers for pulmonary tuberculosis, adenocarcinoma and sarcoidosis. Commun. Biol. 3, 604 (2020).","journal-title":"Commun. Biol."},{"key":"6822_CR17","doi-asserted-by":"publisher","first-page":"7853","DOI":"10.1073\/pnas.1121072109","volume":"109","author":"J Maertzdorf","year":"2012","unstructured":"Maertzdorf, J. et al. Common patterns and disease-related signatures in tuberculosis and sarcoidosis. Proc. Natl Acad. Sci. USA 109, 7853\u20137858 (2012).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"6822_CR18","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.ajo.2021.01.025","volume":"226","author":"A Agarwal","year":"2021","unstructured":"Agarwal, A. et al. Clinical and multimodal imaging clues in differentiating between tuberculomas and sarcoid choroidal granulomas. Am. J. Ophthalmol. 226, 42\u201355 (2021).","journal-title":"Am. J. Ophthalmol."},{"key":"6822_CR19","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1016\/j.survophthal.2021.10.001","volume":"67","author":"HD Alli","year":"2022","unstructured":"Alli, H. D., Ally, N., Mayet, I., Dangor, Z. & Madhi, S. A. Global prevalence and clinical outcomes of tubercular uveitis: a systematic review and meta-analysis. Surv. Ophthalmol. 67, 770\u2013792 (2022).","journal-title":"Surv. Ophthalmol."},{"key":"6822_CR20","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1007\/s12348-011-0021-2","volume":"1","author":"JY Lin","year":"2011","unstructured":"Lin, J. Y. & Sheu, S. J. Ocular sarcoidosis and tuberculous lymphadenopathy: coincidence or real association. J. Ophthalmic Inflamm. Infect. 1, 137\u2013140 (2011).","journal-title":"J. Ophthalmic Inflamm. Infect."},{"key":"6822_CR21","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/j.ijtb.2017.12.016","volume":"66","author":"R Vadala","year":"2019","unstructured":"Vadala, R., Bhat, M. N. M., Rabindrarajan, E. & Ramakrishnan, N. Concomitant presentation of sarcoidosis and pulmonary tuberculosis with ARDS: a diagnostic dilemma and therapeutic challenge. Indian J. Tuberc. 66, 314\u2013317 (2019).","journal-title":"Indian J. Tuberc."},{"key":"6822_CR22","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1080\/09273948.2018.1491997","volume":"27","author":"I Testi","year":"2019","unstructured":"Testi, I., Tognon, M. S. & Gupta, V. Diagnostic challenges in granulomatous uveitis: tuberculosis or sarcoidosis? Ocul. Immunol. Inflamm. 27, 1049\u20131051 (2019).","journal-title":"Ocul. Immunol. Inflamm."},{"key":"6822_CR23","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1001\/jamaophthalmol.2017.5466","volume":"136","author":"YS Han","year":"2018","unstructured":"Han, Y. S., Rivera-Grana, E., Salek, S. & Rosenbaum, J. T. Distinguishing uveitis secondary to sarcoidosis from idiopathic disease: cardiac implications. JAMA Ophthalmol. 136, 109\u2013115 (2018).","journal-title":"JAMA Ophthalmol."},{"key":"6822_CR24","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.ajo.2021.03.040","volume":"228","author":"Standardization of Uveitis Nomenclature Working, G.","year":"2021","unstructured":"Standardization of Uveitis Nomenclature Working, G. Classification criteria for tubercular uveitis. Am. J. Ophthalmol. 228, 142\u2013151 (2021).","journal-title":"Am. J. Ophthalmol."},{"key":"6822_CR25","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1001\/jamaophthalmol.2017.4771","volume":"135","author":"F Groen-Hakan","year":"2017","unstructured":"Groen-Hakan, F. et al. Diagnostic value of serum-soluble interleukin 2 receptor levels vs angiotensin-converting enzyme in patients with sarcoidosis-associated uveitis. JAMA Ophthalmol. 135, 1352\u20131358 (2017).","journal-title":"JAMA Ophthalmol."},{"key":"6822_CR26","first-page":"99","volume":"27","author":"NM Verrills","year":"2006","unstructured":"Verrills, N. M. Clinical proteomics: present and future prospects. Clin. Biochem Rev. 27, 99\u2013116 (2006).","journal-title":"Clin. Biochem Rev."},{"key":"6822_CR27","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1007\/s12010-013-0238-7","volume":"170","author":"AH Zhang","year":"2013","unstructured":"Zhang, A. H., Sun, H., Yan, G. L., Han, Y. & Wang, X. J. Serum proteomics in biomedical research: a systematic review. Appl Biochem. Biotechnol. 170, 774\u2013786 (2013).","journal-title":"Appl Biochem. Biotechnol."},{"key":"6822_CR28","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1038\/nature01514","volume":"422","author":"S Hanash","year":"2003","unstructured":"Hanash, S. Disease proteomics. Nature 422, 226\u2013232 (2003).","journal-title":"Nature"},{"key":"6822_CR29","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1111\/aos.14993","volume":"100","author":"B Schrijver","year":"2022","unstructured":"Schrijver, B. et al. Vitreous proteomics, a gateway to improved understanding and stratification of diverse uveitis aetiologies. Acta Ophthalmol. 100, 403\u2013413 (2022).","journal-title":"Acta Ophthalmol."},{"key":"6822_CR30","doi-asserted-by":"publisher","first-page":"1838","DOI":"10.4103\/ijo.IJO_1325_20","volume":"68","author":"G Patnaik","year":"2020","unstructured":"Patnaik, G., Annamalai, R. & Biswas, J. Intraocular biopsy in uveitis. Indian J. Ophthalmol. 68, 1838\u20131843 (2020).","journal-title":"Indian J. Ophthalmol."},{"key":"6822_CR31","doi-asserted-by":"publisher","first-page":"942","DOI":"10.15252\/msb.20156297","volume":"13","author":"PE Geyer","year":"2017","unstructured":"Geyer, P. E., Holdt, L. M., Teupser, D. & Mann, M. Revisiting biomarker discovery by plasma proteomics. Mol. Syst. Biol. 13, 942 (2017).","journal-title":"Mol. Syst. Biol."},{"key":"6822_CR32","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.1167\/iovs.17-23246","volume":"59","author":"R La Distia Nora","year":"2018","unstructured":"La Distia Nora, R. et al. Retinal Pigment Epithelial Cells Control Early Mycobacterium tuberculosis Infection via Interferon Signaling. Invest Ophthalmol. Vis. Sci. 59, 1384\u20131395 (2018).","journal-title":"Invest Ophthalmol. Vis. Sci."},{"key":"6822_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/srep16882","volume":"5","author":"JD Blischak","year":"2015","unstructured":"Blischak, J. D., Tailleux, L., Mitrano, A., Barreiro, L. B. & Gilad, Y. Mycobacterial infection induces a specific human innate immune response. Sci. Rep. 5, 16882 (2015).","journal-title":"Sci. Rep."},{"key":"6822_CR34","doi-asserted-by":"crossref","unstructured":"Giraud-Gatineau, A. et al. The antibiotic bedaquiline activates host macrophage innate immune resistance to bacterial infection. Elife 9 (2020).","DOI":"10.7554\/eLife.55692"},{"key":"6822_CR35","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.cytogfr.2013.04.003","volume":"24","author":"FB Vincent","year":"2013","unstructured":"Vincent, F. B., Saulep-Easton, D., Figgett, W. A., Fairfax, K. A. & Mackay, F. The BAFF\/APRIL system: emerging functions beyond B cell biology and autoimmunity. Cytokine Growth Factor Rev. 24, 203\u2013215 (2013).","journal-title":"Cytokine Growth Factor Rev."},{"key":"6822_CR36","first-page":"72","volume":"36","author":"K Hashemzadeh","year":"2021","unstructured":"Hashemzadeh, K. et al. Serum B cell activating factor (BAFF) and sarcoidosis activity. Arch. Rheumatol. 36, 72\u201379 (2021).","journal-title":"Arch. Rheumatol."},{"key":"6822_CR37","doi-asserted-by":"publisher","first-page":"1658","DOI":"10.1093\/rheumatology\/ket186","volume":"52","author":"I Ueda-Hayakawa","year":"2013","unstructured":"Ueda-Hayakawa, I. et al. Elevated serum BAFF levels in patients with sarcoidosis: association with disease activity. Rheumatol. (Oxf.) 52, 1658\u20131666 (2013).","journal-title":"Rheumatol. (Oxf.)"},{"key":"6822_CR38","doi-asserted-by":"publisher","first-page":"2833","DOI":"10.1007\/s10067-018-4183-2","volume":"37","author":"M Ando","year":"2018","unstructured":"Ando, M. et al. Significant elevation of the levels of B-cell activating factor (BAFF) in patients with sarcoidosis. Clin. Rheumatol. 37, 2833\u20132838 (2018).","journal-title":"Clin. Rheumatol."},{"key":"6822_CR39","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-57741-0","volume":"10","author":"I Kudryavtsev","year":"2020","unstructured":"Kudryavtsev, I. et al. Imbalance in B cell and T follicular helper cell subsets in pulmonary sarcoidosis. Sci. Rep. 10, 1059 (2020).","journal-title":"Sci. Rep."},{"key":"6822_CR40","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1164\/rccm.201206-1024OC","volume":"187","author":"LS Kamphuis","year":"2013","unstructured":"Kamphuis, L. S. et al. Perigranuloma localization and abnormal maturation of B cells: emerging key players in sarcoidosis? Am. J. Respir. Crit. Care Med. 187, 406\u2013416 (2013).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"6822_CR41","doi-asserted-by":"publisher","first-page":"e43588","DOI":"10.1371\/journal.pone.0043588","volume":"7","author":"A Saussine","year":"2012","unstructured":"Saussine, A. et al. Active chronic sarcoidosis is characterized by increased transitional blood B cells, increased IL-10-producing regulatory B cells and high BAFF levels. PLoS ONE 7, e43588 (2012).","journal-title":"PLoS ONE"},{"key":"6822_CR42","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1080\/09273948.2019.1604974","volume":"28","author":"AM Abu El-Asrar","year":"2020","unstructured":"Abu El-Asrar, A. M. et al. Local cytokine expression profiling in patients with specific autoimmune uveitic entities. Ocul. Immunol. Inflamm. 28, 453\u2013462 (2020).","journal-title":"Ocul. Immunol. Inflamm."},{"key":"6822_CR43","first-page":"2675","volume":"260","author":"A Takeda","year":"2022","unstructured":"Takeda, A. et al. Increased vitreous levels of B cell activation factor (BAFF) and soluble interleukin-6 receptor in patients with macular edema due to uveitis related to Beh\u00e7et\u2019s disease and sarcoidosis. Graefes Arch. Clin. Exp. Ophthalmol. 260, 2675\u20132686 (2022).","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"6822_CR44","doi-asserted-by":"publisher","first-page":"6961","DOI":"10.4049\/jimmunol.0904176","volume":"184","author":"M Al-Alwan","year":"2010","unstructured":"Al-Alwan, M., Hou, S., Zhang, T. T., Makondo, K. & Marshall, A. J. Bam32\/DAPP1 promotes B cell adhesion and formation of polarized conjugates with T cells. J. Immunol. 184, 6961\u20136969 (2010).","journal-title":"J. Immunol."},{"key":"6822_CR45","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1093\/intimm\/dxn039","volume":"20","author":"CL Sommers","year":"2008","unstructured":"Sommers, C. L. et al. Bam32: a novel mediator of Erk activation in T cells. Int Immunol. 20, 811\u2013818 (2008).","journal-title":"Int Immunol."},{"key":"6822_CR46","doi-asserted-by":"publisher","DOI":"10.1186\/s12948-015-0025-9","volume":"13","author":"F Cinetto","year":"2015","unstructured":"Cinetto, F., Compagno, N., Scarpa, R., Malipiero, G. & Agostini, C. Rituximab in refractory sarcoidosis: a single centre experience. Clin. Mol. Allergy 13, 19 (2015).","journal-title":"Clin. Mol. Allergy"},{"key":"6822_CR47","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.cardfail.2021.07.008","volume":"28","author":"M Elwazir","year":"2022","unstructured":"Elwazir, M. et al. Rituximab for the treatment of refractory cardiac sarcoidosis: a single-center experience. J. Card. Fail 28, 247\u2013258 (2022).","journal-title":"J. Card. Fail"},{"key":"6822_CR48","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.molimm.2019.04.012","volume":"111","author":"AG Loxton","year":"2019","unstructured":"Loxton, A. G. Bcells and their regulatory functions during tuberculosis: latency and active disease. Mol. Immunol. 111, 145\u2013151 (2019).","journal-title":"Mol. Immunol."},{"key":"6822_CR49","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1038\/s41590-023-01476-3","volume":"24","author":"RV Swanson","year":"2023","unstructured":"Swanson, R. V. et al. Antigen-specific B cells direct T follicular-like helper cells into lymphoid follicles to mediate Mycobacterium tuberculosis control. Nat. Immunol. 24, 855\u2013868 (2023).","journal-title":"Nat. Immunol."},{"key":"6822_CR50","doi-asserted-by":"publisher","first-page":"e1005687","DOI":"10.1371\/journal.ppat.1005687","volume":"12","author":"SA Joosten","year":"2016","unstructured":"Joosten, S. A. et al. Patients with tuberculosis have a dysfunctional circulating b-cell compartment, which normalizes following successful treatment. PLoS Pathog. 12, e1005687 (2016).","journal-title":"PLoS Pathog."},{"key":"6822_CR51","doi-asserted-by":"crossref","unstructured":"Komatsu, H. et al. Comprehensive proteomic profiling of vitreous humor in ocular sarcoidosis compared with other vitreoretinal diseases. J. Clin. Med. 11 (2022).","DOI":"10.3390\/jcm11133606"},{"key":"6822_CR52","doi-asserted-by":"publisher","DOI":"10.1016\/j.tube.2020.102036","volume":"126","author":"R Bansal","year":"2021","unstructured":"Bansal, R. et al. Proteomic profile of vitreous in patients with tubercular uveitis. Tuberculosis (Edinb.) 126, 102036 (2021).","journal-title":"Tuberculosis (Edinb.)"},{"key":"6822_CR53","doi-asserted-by":"publisher","first-page":"488","DOI":"10.3109\/09273948.2010.525730","volume":"18","author":"AW Taylor","year":"2010","unstructured":"Taylor, A. W. & Kaplan, H. J. Ocular immune privilege in the year 2010: ocular immune privilege and uveitis. Ocul. Immunol. Inflamm. 18, 488\u2013492 (2010).","journal-title":"Ocul. Immunol. Inflamm."},{"key":"6822_CR54","doi-asserted-by":"publisher","first-page":"e1533","DOI":"10.1111\/aos.15093","volume":"100","author":"B Schrijver","year":"2022","unstructured":"Schrijver, B. et al. Serum CCL17 distinguishes sarcoid uveitis from TB-uveitis and QFT-negative uveitis. Acta Ophthalmol. 100, e1533\u2013e1534 (2022).","journal-title":"Acta Ophthalmol."},{"key":"6822_CR55","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2022.577849","volume":"367","author":"KE Byg","year":"2022","unstructured":"Byg, K. E. et al. Inflammatory profiles in plasma and cerebrospinal fluid of patients with neurosarcoidosis. J. Neuroimmunol. 367, 577849 (2022).","journal-title":"J. Neuroimmunol."},{"key":"6822_CR56","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1080\/08977190410001704679","volume":"22","author":"KC Wilson","year":"2004","unstructured":"Wilson, K. C., Center, D. M. & Cruikshank, W. W. The effect of interleukin-16 and its precursor on T lymphocyte activation and growth. Growth Factors 22, 97\u2013104 (2004).","journal-title":"Growth Factors"},{"key":"6822_CR57","doi-asserted-by":"publisher","first-page":"e1002781","DOI":"10.1371\/journal.pmed.1002781","volume":"16","author":"A Penn-Nicholson","year":"2019","unstructured":"Penn-Nicholson, A. et al. Discovery and validation of a prognostic proteomic signature for tuberculosis progression: a prospective cohort study. PLoS Med 16, e1002781 (2019).","journal-title":"PLoS Med"},{"key":"6822_CR58","doi-asserted-by":"publisher","first-page":"3308","DOI":"10.1002\/jcb.25983","volume":"118","author":"M Otsuka","year":"2017","unstructured":"Otsuka, M., Okinaga, T., Ariyoshi, W., Kitamura, C. & Nishihara, T. Ameloblastin upregulates inflammatory response through induction of IL-1\u03b2 in human macrophages. J. Cell Biochem 118, 3308\u20133317 (2017).","journal-title":"J. Cell Biochem"},{"key":"6822_CR59","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1165\/rcmb.2016-0321OC","volume":"57","author":"ED Crouser","year":"2017","unstructured":"Crouser, E. D. et al. A novel in vitro human granuloma model of sarcoidosis and latent tuberculosis infection. Am. J. Respir. Cell Mol. Biol. 57, 487\u2013498 (2017).","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"6822_CR60","doi-asserted-by":"publisher","first-page":"e0194430","DOI":"10.1371\/journal.pone.0194430","volume":"13","author":"D Silva","year":"2018","unstructured":"Silva, D. et al. TNF-\u03b1 blockade impairs in vitro tuberculous granuloma formation and down modulate Th1, Th17 and Treg cytokines. PLoS ONE 13, e0194430 (2018).","journal-title":"PLoS ONE"},{"key":"6822_CR61","doi-asserted-by":"publisher","first-page":"e38083","DOI":"10.1371\/journal.pone.0038083","volume":"7","author":"M Thillai","year":"2012","unstructured":"Thillai, M. et al. Sarcoidosis and tuberculosis cytokine profiles: indistinguishable in bronchoalveolar lavage but different in blood. PLoS ONE 7, e38083 (2012).","journal-title":"PLoS ONE"},{"key":"6822_CR62","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1038\/nature09247","volume":"466","author":"MP Berry","year":"2010","unstructured":"Berry, M. P. et al. An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis. Nature 466, 973\u2013977 (2010).","journal-title":"Nature"},{"key":"6822_CR63","doi-asserted-by":"publisher","first-page":"e0154716","DOI":"10.1371\/journal.pone.0154716","volume":"11","author":"C Fang","year":"2016","unstructured":"Fang, C., Huang, H. & Xu, Z. Immunological evidence for the role of Mycobacteria in sarcoidosis: a meta-analysis. PLoS ONE 11, e0154716 (2016).","journal-title":"PLoS ONE"},{"key":"6822_CR64","doi-asserted-by":"crossref","unstructured":"Malkova, A. et al. The opposite effect of human leukocyte antigen genotypes in sarcoidosis and tuberculosis: a narrative review of the literature. ERJ Open Res. 6 (2020).","DOI":"10.1183\/23120541.00155-2020"},{"key":"6822_CR65","doi-asserted-by":"publisher","first-page":"e26","DOI":"10.1164\/rccm.202002-0251ST","volume":"201","author":"ED Crouser","year":"2020","unstructured":"Crouser, E. D. et al. Diagnosis and Detection of Sarcoidosis. An Official American Thoracic Society Clinical Practice Guideline. Am. J. Respir. Crit. Care Med 201, e26\u2013e51 (2020).","journal-title":"Am. J. Respir. Crit. Care Med"},{"key":"6822_CR66","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1136\/bjophthalmol-2018-313356","volume":"103","author":"M Mochizuki","year":"2019","unstructured":"Mochizuki, M. et al. Revised criteria of International Workshop on Ocular Sarcoidosis (IWOS) for the diagnosis of ocular sarcoidosis. Br. J. Ophthalmol. 103, 1418\u20131422 (2019).","journal-title":"Br. J. Ophthalmol."},{"key":"6822_CR67","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1038\/eye.2017.231","volume":"32","author":"R La Distia Nora","year":"2018","unstructured":"La Distia Nora, R. et al. Tuberculosis and other causes of uveitis in Indonesia. Eye (Lond.) 32, 546\u2013554 (2018).","journal-title":"Eye (Lond.)"},{"key":"6822_CR68","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1016\/j.ajo.2013.11.013","volume":"157","author":"R La Distia Nora","year":"2014","unstructured":"La Distia Nora, R. et al. Clinical manifestations of patients with intraocular inflammation and positive QuantiFERON-TB gold in-tube test in a country nonendemic for tuberculosis. Am. J. Ophthalmol. 157, 754\u2013761 (2014).","journal-title":"Am. J. Ophthalmol."},{"key":"6822_CR69","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1111\/aos.13877","volume":"97","author":"A Rothova","year":"2019","unstructured":"Rothova, A., Hajjaj, A., de Hoog, J., Thiadens, A. & Dalm, V. Uveitis causes according to immune status of patients. Acta Ophthalmol. 97, 53\u201359 (2019).","journal-title":"Acta Ophthalmol."},{"key":"6822_CR70","doi-asserted-by":"publisher","first-page":"e0162220","DOI":"10.1371\/journal.pone.0162220","volume":"11","author":"S Blankley","year":"2016","unstructured":"Blankley, S. et al. The transcriptional signature of active tuberculosis reflects symptom status in extra-pulmonary and pulmonary tuberculosis. PLoS ONE 11, e0162220 (2016).","journal-title":"PLoS ONE"}],"container-title":["Communications Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s42003-024-06822-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-024-06822-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-024-06822-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,10]],"date-time":"2024-09-10T19:07:02Z","timestamp":1725995222000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s42003-024-06822-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,10]]},"references-count":70,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["6822"],"URL":"https:\/\/doi.org\/10.1038\/s42003-024-06822-1","relation":{},"ISSN":["2399-3642"],"issn-type":[{"value":"2399-3642","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,10]]},"assertion":[{"value":"6 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1114"}}